1 e gloves) and applying emollients and potent topical glucocorticoids.

2  children who fail to respond as expected to topical glucocorticoids.

3 ere atopic dermatitis despite treatment with topical glucocorticoids and calcineurin inhibitors.

4 s shown that over 80% of patients prescribed topical glucocorticoids are fearful of side effects and

5    We investigated whether cytokines and the topical glucocorticoid budesonide differentially regulat

6 similar magnitude to that seen with a potent topical glucocorticoid, clobetasol.

7                                              Topical glucocorticoids continue to be well tolerated, e

8                                   The potent topical glucocorticoid fluticasone propionate significan

9 d healing are the recognized side effects of topical glucocorticoid (GC) therapy.

10 in one 12-week trial and in combination with topical glucocorticoids in another 4-week study.

11 how in vitro and in vivo that treatment with topical glucocorticoids leads to rapid restoration of gl

12                                              Topical glucocorticoid therapy, with or without concurre

13  monograph reviews recent studies, examining topical glucocorticoid use in children.

14 Risk of cataract development associated with topical glucocorticoid use is better defined.

15 corticoids used less than half the amount of topical glucocorticoids used by those who received place

16 , as compared with 50% of those who received topical glucocorticoids with placebo injection, met the